selenious acid has been researched along with Smith-Lemli-Opitz Syndrome in 1 studies
Selenious Acid: A selenium compound with the molecular formula H2SO3. It used as a source of SELENIUM, especially for patients that develop selenium deficiency following prolonged PARENTERAL NUTRITION.
Smith-Lemli-Opitz Syndrome: An autosomal recessive disorder of CHOLESTEROL metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple CONGENITAL ABNORMALITIES, growth deficiency, and INTELLECTUAL DISABILITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fliesler, SJ | 1 |
| Peachey, NS | 1 |
| Herron, J | 1 |
| Hines, KM | 1 |
| Weinstock, NI | 1 |
| Ramachandra Rao, S | 1 |
| Xu, L | 1 |
1 other study available for selenious acid and Smith-Lemli-Opitz Syndrome
| Article | Year |
|---|---|
Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome.
Topics: Animals; Antioxidants; Cholesterol; Dietary Supplements; Female; Rats; Rats, Sprague-Dawley; Retina; | 2018 |